MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-01-0028494
Libraw Pharma Excipients Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹30.37 Cr
▲ 12% YoY
Net profit · FY 2025
₹34.54 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹52 Lakh
EBITDA margin 1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
About Libraw Pharma Excipients Private Limited
Data last updated:
Libraw Pharma Excipients Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 July 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC401836.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Inder Pal Malik and Shuchi Malik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14 Rani Jhansi Road Paharganj Delhi – 110055, New Delhi, Delhi, India – 110055.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.37 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹34.54 Lakh (net margin 1.1%) and EBITDA of ₹52 Lakh (EBITDA margin 1.7%).
The company is associated with 2 brands: Librawpharma and Libraw Pharma. As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
Libraw Pharma Excipients Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-01-0028494). For more details, the company can be reached via its website pharma-excipients.com.
Company details
CIN U24290DL2022PTC401836
Registration Number 401836
Incorporation Date 15 July 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-DL-01-0028494
Recognitions & Rankings of Libraw Pharma Excipients
Contact details
Libraw Pharma Excipients Private Limited's registered office is in New Delhi, Delhi. Its website is pharma-excipients.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address14 Rani Jhansi Road Paharganj Delhi – 110055, New Delhi, Delhi, India – 110055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Libraw Pharma Excipients Private Limited, buy the company report.
Comprehensive company report
Libraw Pharma Excipients Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Libraw Pharma Excipients operates two associated brands: Librawpharma and Libraw Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Libraw Pharma produces excipients for tablets, liquids, injectables, and ointments for export. | librawpharma.in | |
| Manufacturer of pharmaceutical excipients, specialty chemicals, and pharmaceutical chemicals | librawpharma.com |
Business activity
The main business activity of Libraw Pharma Excipients is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Libraw Pharma Excipients Private Limited, buy the company report.
Financials of Libraw Pharma Excipients Private Limited
FY 2025 filings availableLibraw Pharma Excipients Private Limited reported revenue of ₹30.37 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹30.37 Cr ▲ 12%
Net profit · FY 2025
₹34.54 Lakh margin 1.1%
EBITDA · FY 2025
₹52 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
EBITDA CAGR growth
1 year
▲ 6%
Revenue rose 12% in the latest year. EBITDA rose 6% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹52 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹34.54 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.7% | ||
| Net Profit Margin | 1.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Libraw Pharma Excipients Private Limited, buy the company report.
Board of directors of Libraw Pharma Excipients Private Limited
Libraw Pharma Excipients has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inder Pal Malik | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Shuchi Malik | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Dhruv Malik | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
Libraw Pharma Excipients Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Algen Healthcare Limited | ₹30.69 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Glendale Biomed Private Limited | ₹30.54 Cr (FY 2023) | 51.0% | Mumbai, Maharashtra, India | |||
| Hauz Pharma Private Limited | ₹30.46 Cr (FY 2024) | 14.0% | Chandigarh, India | |||
| Libraw Pharma Excipients Private Limitedthis company | ₹30.37 Cr (FY 2025) | ₹34.54 Lakh | 1.1% | 12.0% | New Delhi, Delhi, India | |
| Psa Chemicals and Pharmaceuticals Pvt Ltd | ₹30.31 Cr (FY 2025) | 4.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Libraw Pharma Excipients Private Limited, buy the company report.
Auditor
Libraw Pharma Excipients Private Limited is audited by AMIT KUMAR for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT KUMAR | FY 2023 | 561747 |
Shareholding
The shareholding of Libraw Pharma Excipients Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Libraw Pharma Excipients Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2025 | 101199340 | Hdfc Bank Limited | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Libraw Pharma Excipients Private Limited has 3 court cases on record: 3 filed by Libraw Pharma Excipients. All cases are pending.
Total cases
3
Filed by the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against Bisista Pharma Pvt Ltd | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Libraw Pharma Excipients Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Libraw Pharma Excipients Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Libraw Pharma Excipients Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Libraw Pharma Excipients Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Libraw Pharma Excipients Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Dhruv Malik was appointed as Director on 15 Jul 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 101199340 was registered on 21 Nov 2025.
AGM
Libraw Pharma Excipients Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Libraw Pharma Excipients Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Dhruv Malik was appointed as Director.
Appointed
Inder Pal Malik was appointed as Director.
Appointed
Shuchi Malik was appointed as Director.
Incorporation
15 Jul 2022
Libraw Pharma Excipients Private Limited was registered on 15 Jul 2022 with Roc Delhi & aged 4 years 3 months as per MCA records.
Frequently asked questions
Libraw Pharma Excipients is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 July 2022 (4+ years old) and is registered under CIN U24290DL2022PTC401836.
Libraw Pharma Excipients has 3 current directors:
- Inder Pal Malik - Director
- Shuchi Malik - Director
- Dhruv Malik - Director
The latest financial statements of Libraw Pharma Excipients on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Libraw Pharma Excipients is U24290DL2022PTC401836. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Libraw Pharma Excipients has 3 court cases on record: 3 filed by the company. 3 are pending.
Libraw Pharma Excipients was incorporated on 15 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Libraw Pharma Excipients by revenue are Algen Healthcare Limited, Glendale Biomed Private Limited, Hauz Pharma Private Limited, Psa Chemicals and Pharmaceuticals Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Dhruv Malik was appointed as Director on 15 Jul 2022. Inder Pal Malik was appointed as Director on 15 Jul 2022. Shuchi Malik was appointed as Director on 15 Jul 2022.
Yes, Libraw Pharma Excipients is registered as an MSME under Udyam registration (number: UDYAM-DL-01-0028494).
Libraw Pharma Excipients can be reached through the website pharma-excipients.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Libraw Pharma Excipients is at 14 Rani Jhansi Road Paharganj Delhi – 110055, New Delhi, Delhi, India – 110055.